Study: Cholesterol drugs may improve flu survival
A new treatment for swine flu may already be on pharmacy shelves — cholesterol-lowering statin drugs like Lipitor and Zocor.
A large study found that people who were taking these drugs when they caught seasonal flu and had to be hospitalized were twice as likely to survive than those who were not on such medicines.
This doesn’t prove that statins can cure flu, or that starting on them after catching the flu would help. A federal study is under way now to test that. Doctors are optimistic, because previous studies also found that statins may improve survival from infectious diseases.
“It’s very promising,” said the new study’s leader, Dr. Ann Thomas of the Oregon Public Health Division. Results were discussed Thursday at an Infectious Diseases Society of America conference in Philadelphia.
“It’s intriguing and exciting,” and the benefit seen from statins is “substantial,” said Dr. William Schaffner, a Vanderbilt University doctor whose hospital in Nashville, Tenn., was involved in the research.
“There are relatively few downsides to trying statins,” which are cheap, relatively safe, and already among the most widely used medicines in the world, he said.
Treatment is a crucial issue for swine flu because vaccine is slow to reach the public, and flu medicines like Tamiflu are being reserved for only the sickest patients.
Statins have long been known to reduce inflammation along with cholesterol. Much of the damage that flu causes, whether it’s seasonal or the new H1N1 virus, is from inflammation and an overreaction by the immune system as it fights the virus.
Earlier studies found that statins improved survival from pneumonia and serious bacterial bloodstream infections. The new research, sponsored by the federal Centers for Disease Control and Prevention, is the first large one in the United States to look at statins for flu.
It involved 2,800 people hospitalized with lab-confirmed seasonal flu in 10 states in 2007-2008. Medical records show that 801 received statins in the hospital. They probably were just continuing the cholesterol treatment they had been taking before catching the flu, though researchers don’t know this for sure.
More than 3 percent of those not taking statins died in the hospital or in the following month. The rate was half that among statin users, even though they were more likely to have underlying health problems like heart disease. Researchers took other factors such as age into account and still saw the same benefit from statin use.
“It’s an important study,” said Dr. Andrew Pavia, a pediatrics professor at the University of Utah and head of the infectious disease society’s pandemic flu task force. He said he now places a high priority on testing statins as a treatment.
“It gives us a pretty cost-effective tool if it works,” he said.
There might be justification for trying these drugs now in certain patients not doing well on any other treatment, said Dr. Ronald Turner of the University of Virginia, a prominent virologist who had no role in the new study.
“If you get yourself to the point where you don’t have anything to offer and things are going poorly for the patient, then maybe to try something on a speculative note is appropriate,” he said.
The statin study is the second piece of good news on the treatment front in a week. Last Friday, the federal Food and Drug Administration authorized emergency use of the experimental drug peramivir as a swine flu treatment.
Recent results from an Asian study showed that a single intravenous dose of peramivir (purr-AM-uh-veer) cleared up flu symptoms as effectively as five days of Tamiflu pills. Some very sick patients need IV treatments because they can’t swallow pills or absorb the medicine well.
BioCryst Pharmaceuticals Inc. of Birmingham, Ala., is developing peramivir with Japan-based Shionogi & Co.
Statins are available in generic form and also sold as Lipitor by Pfizer Inc.; Zocor by Merck & Co.; Crestor by AstraZeneca PLC, and Pravachol by Bristol-Myers Squibb Co., among others.
On the Net:
Conference: www.idsociety.org/IDSA2009.htm
Related News
Common cholesterol-lowering drug could prevent Parkinson's progressionOctober 30th, 2009 WASHINGTON - A commonly used cholesterol-lowering drug, called simvastatin, can prevent progression of Parkinson's disease, according to a study by neurological researchers at Rush University Medical Center. The study examined the use of the FDA-approved medication in mice with Parkinson's disease and found that the drug successfully reverses the biochemical, cellular and anatomical changes caused by the disease.
Statins can have both beneficial and detrimental effects on brain cellsOctober 29th, 2009 WASHINGTON - Apart from treating high cholesterol and lowering the risk of heart disease, statins have also been found to potentially reduce the risks of other diseases, such as dementia. But, a new study has shown that similar statin drugs can have profoundly different effects on brain cells - both beneficial and harmful.
Statins may be effective against cancerOctober 28th, 2009 WASHINGTON - Cholesterol-lowering medicines, also known as statins, can prove effective in the treatment of cancer, says a new study. The research from the University of Gothenburg has been published in the prestigious journal PNAS.
Epilepsy drugs may help treat Alzheimer's and Parkinson'sOctober 28th, 2009 WASHINGTON - A potential new function for anti-epileptic drugs in treating neurodegenerative disorders such as Alzheimer's and Parkinson's has been discovered by US researchers. The study, published in BioMed Central's open access journal Molecular Neurodegeneration, found that neurons in the brain were protected after treatment with T-type calcium-channel blockers, which are commonly used to treat epilepsy.
Cholesterol drugs may be effective against cancer tooOctober 28th, 2009 LONDON - Millions of people worldwide use statins, a class of drugs used to lower blood cholesterol, but new research shows they may also be effective against cancer. Statins lower cholesterol by blocking certain enzymes involved in our metabolism.
Drugmaker Pfizer's 3Q profit jumps 26 percent on cost cuts; more expected with Wyeth deal doneOctober 20th, 2009 Pfizer 3Q profit jumps 26 percent on cost cuttingTRENTON, N.J. — Drugmaker Pfizer Inc.
Nanomedicine has huge potential in India, experts sayOctober 15th, 2009 NEW DELHI - India, with over a billion population, has a huge market potential for nanomedicine, and nano drugs can improve the healthcare system in the country, experts said Thursday. "Nanotechnology has bright growth prospects in India and other third world countries.
Green tea can slash cancer riskOctober 15th, 2009 LONDON - Five cups of green tea every day can cut the risk of developing certain blood cancers, say researchers. The much touted beverage, drunk in China, Japan and the Middle East, has been previously shown to have a host of benefits including staving off cancers, helping the heart, boosting the brain and lowering levels of "bad" cholesterol.
Cholesterol crucial to brain developmentOctober 3rd, 2009 WASHINGTON - Swedish researchers have shown that a derivative of cholesterol is necessary for the formation of brain cells by conducting experiments on mice. Professor Ernest Arenas, from the medical university Karolinska Institutet, says that the study's findings may prove helpful for scientists in cultivating dopamine-producing cells outside the body.
Indian American finds weight loss is good for kidneysSeptember 18th, 2009 WASHINGTON - Shedding pounds can help patients of kidney diseases protect their health, says a new study led by an Indian American. More than a third of US adults are either obese or overweight.
Middle-aged smokers with high cholesterol, BP 'cut life short by 10yrs'September 18th, 2009 LONDON - Middle-aged smokers with high cholesterol and blood pressure face a ten-year cut in their lives, warns a new study. The warning follows an Oxford University study of 19,000 men over an average of 38 years.
Statins may help treat 'female sexual dysfunction'September 9th, 2009 LONDON - Cholesterol-lowering wonder drugs known as statins may help treat female sexual dysfunction (FSD), according to a new study. Raised cholesterol levels, or hyperlipidemia, have been linked to erectile dysfunction in men, as the build-up of fats in blood vessel walls can reduce blood flow to erectile tissue.
Lung cancer patients' pre-treatment life quality can predict odds of survivalSeptember 4th, 2009 WASHINGTON - A lung cancer patient's likelihood of survival can be predicted by looking at his/her quality of life before the treatment, according to a study. Led by Dr. Yingwei Qi, a team of researchers at the Mayo Clinic Rochester in Minnesota conducted a pooled analysis of research from six different clinical trials, representing 420 patients with advanced stage non-small cell lung cancer (NSCLC).
Research shows statin use reduces heart attacks, deaths after surgery on blood vesselsSeptember 2nd, 2009 Statin cuts heart problems after artery surgeryNEW YORK — Score another victory for the cheap, cholesterol-lowering wonder drugs known as statins. People getting an artery unclogged or repaired were much less likely to die or have a heart attack afterward if they took preventive doses of the pills before and after their operations, a Dutch study showed.
Healthy eating, weight loss improve cardiac risk factorsAugust 30th, 2009 WASHINGTON - Weight loss achieved through regular exercise and a heart-healthy diet can help improve cardiac risk factors, suggests a cardiologist. Dr Philip Ades said that mild caloric restriction improves insulin resistance and improves a host of other cardiac risk factors, such as blood pressure, cholesterol level, clotting measures and measures of inflammation.
October 31st, 2009 at 7:42 am
European Journal of Pharmaceutical Sciences July 2009
Journal homepage: http://www.elsevier.com/locate/ejps
Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice.
a b s t r a c t
The development of novel antiviral drugs is necessary for the prevention and treatment of a potential avian influenza pandemic. The aim of this study was to evaluate the efficacy and safety of a novel statin/caffeine combination against H5N1,H3N2 and H1N1virus infection in a murine model. In H5N1-, H3N2- and H1N1- infected BALB/c mice, 50g statin/200g caffeine effectively ameliorated lung damage and inhibited viral replication and was at least as effective as oseltamivir(Tamiflu) and Ribavirin. The statin/caffeine combination also appeared to be more effective when administered preventatively rather than as treatment. These findings provide justification for further research into this novel antiviral formulation.
Authors: Zeyu Liua,c, Zhongmin Guob, GuolingWangc, Dingmei Zhanga, Hongxuan Hed, Guowei Li a,
Yuge Liua, Denise Higginse, AoiffeWalshe, Leo Shanahan-Prendergast e, Jiahai Lua,∗
a School of Public Health, State Ministry of Education Key Laboratory of Tropical Diseases Control Research, Sun Yat-sen University,
74# Zhongshan 2 Road, Guangzhou 510080, PR China
b Experiment Animal Center, Sun Yat-sen University, Guangzhou 510080, PR China
c Haizhu Center for Disease Control and Prevention, Guangzhou 510288, PR China
d National Research Centre for Wildlife Borne Disease Institute of Zoology, Chinese Academy of Sciences, Beijing 100080, PR China
e Canopus BioPharma, 11825 Ventura Blvd., Los Angeles, CA 91604, USA